Anika Therapeutics (ANIK) Change in Acquisitions & Divestments (2015 - 2021)

Anika Therapeutics (ANIK) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $2.5 million the latest figure, recorded in Q1 2021.

• In Q1 2021, Change in Acquisitions & Divestments fell 83.32% year-over-year to $2.5 million; the TTM figure through Dec 2021 stood at $2.5 million (down 94.44% YoY), while the FY2021 annual figure was $2.5 million, down 94.44% from the prior year.
• Change in Acquisitions & Divestments fell to $2.5 million in Q1 2021 per ANIK's latest filing, from $18.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $58.8 million in Q4 2019 and bottomed at $2.5 million in Q1 2021.
• Historically, Change in Acquisitions & Divestments has averaged $16.6 million across 5 years, with a median of $11.5 million in 2018.
• Annual changes were most pronounced in 2019 — Change in Acquisitions & Divestments jumped 411.06% — and 2021, when it plunged 83.32%.
• Anika Therapeutics' Change in Acquisitions & Divestments stood at $10.2 million in 2017, then climbed by 12.2% to $11.5 million in 2018, then surged by 411.06% to $58.8 million in 2019, then sank by 69.37% to $18.0 million in 2020, then slumped by 86.11% to $2.5 million in 2021.
• Business Quant data shows ANIK's Change in Acquisitions & Divestments at $2.5 million in Q1 2021, $18.0 million in Q4 2020, and $7.0 million in Q3 2020.